Waldencast Reports Q2 2024 Financial Results
Waldencast plc (NASDAQ: WALD) has announced its financial results for the second quarter of 2024, revealing net revenue of $63.3 million. This marks a significant increase compared to the previous year, with a notable 25.7% growth in comparable revenue. The company’s brands, Obagi Medical and Milk Makeup, contributed to this success, showing impressive growth rates of +30.9% and +20.0%, respectively, when compared to Q2 2023. Additionally, the adjusted EBITDA for this quarter reached $6.3 million, reflecting a remarkable 64.5% increase from Q2 2023.
Leadership Insights
Michel Brousset, the Founder and CEO of Waldencast, expressed his satisfaction with the company's ongoing growth. He stated, "We are excited to report a continued upward trajectory in our net revenue. The solid figures we’re recording in Q2, paired with the growth of 21% achieved in Q1 2024, reflect our strategic execution and market positioning. We remain optimistic about the second half of the year and are positioned to exceed our FY 2024 outlook, anticipating a comparable growth rate that's higher than our Q2 performance, and an Adjusted EBITDA for H2 2024 that surpasses H1 levels."
Brand Development
Waldencast takes great pride in its brands, particularly Milk Makeup and Obagi Medical, which are both well-positioned for ongoing success in their markets. In the first half of 2024, Milk Makeup saw an impressive 100% year-on-year increase in Earned Media Value (EMV), while Obagi Medical experienced a remarkable 165% growth in EMV. This growth highlights the rising consumer engagement and brand recognition within the fast-paced beauty sector.
Recent product innovations have played a key role in this performance. Notably, Milk Makeup's Viral Cooling Jelly Tint and Obagi Medical's Daily Hydro-Drops Rejuvenating Eye Gel Cream have received positive feedback, leading to rapid sellouts.
Financial Performance Overview
Waldencast's net revenue for Q2 2024 reached $63.3 million, up from $49.4 million in Q2 2023, which translates to a growth of 28.2% on a net revenue basis. When adjusting for product sales related to the former Obagi Medical China Business, the comparable revenue growth stands at 25.7%. Both brands have experienced accelerated growth, particularly in higher-margin e-commerce sales. However, some markets faced challenges due to product out-of-stocks.
Gross Profit and Adjusted EBITDA
The gross profit for Q2 2024 was $44.6 million, compared to $31.2 million in Q2 2023. The Adjusted Gross Profit margin improved significantly to 75.0%, up from 68.5%, thanks to enhanced operations and strategic pricing adjustments. Furthermore, the Group’s Adjusted EBITDA for Q2 2024 was recorded at $6.3 million, demonstrating substantial growth from the previous year’s $3.9 million.
Liquidity and Future Outlook
The company maintains a strong liquidity position, with $19.7 million in cash and cash equivalents and $155.0 million in net debt as of June 30, 2024. Waldencast anticipates continued net revenue growth in the latter half of the year, aiming for a mid-teens Adjusted EBITDA margin for the full year.
Market Positioning and Community Engagement
With a strong commitment to high-quality products and consumer engagement, Waldencast is preparing to launch exciting new initiatives across its brands in the upcoming quarters. The company aims to reinforce its brand identity while focusing on operational effectiveness to drive profitable growth as it continues to expand in the global beauty market.
Frequently Asked Questions
What were Waldencast’s net revenues for Q2 2024?
Waldencast reported net revenues of $63.3 million for Q2 2024.
What is the comparable growth percentage for Waldencast?
The company experienced a comparable growth of 25.7% in Q2 2024.
What is the significance of Milk Makeup's performance?
Milk Makeup achieved a 100% increase in Earned Media Value, showcasing strong consumer demand and brand presence.
What are Waldencast's expectations for the future?
The company anticipates accelerated net revenue growth in H2 2024, exceeding the current rates achieved in Q2.
How does Waldencast plan to enhance its market presence?
Waldencast aims to leverage robust community engagement and product innovation to strengthen its market position globally.
